RxDoctor Payments Data

Rodney Schlosser, MD

Otolaryngology · Charleston, SCNPI 1992818538

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $321,067 of the $381,729 with a category attached, or 84.1%. Stryker accounts for 76.3% of it on its own, with 13 other manufacturers making up the rest. Among otolaryngology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$381,729in general payments, 2019–2025

Across 445 payments — averaging $857.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$291K
  • Olympus Corporation Of The Americas$23K
  • Optinose US, Inc.$20K
  • GSK$15K
  • Sanofi$11K
  • Medtronic$9K
  • plus $12K from 8 others
$261,295in research payments, 2019–2025

Across 64 payments — averaging $4082.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Optinose US, Inc.$67K
  • Roche Products Limited$57K
  • AstraZeneca$35K
  • Stryker$34K
  • Sanofi US Services Inc.$27K
  • GSK$17K
  • plus $25K from 4 others

What the payments were for

  • Consulting fees$321,06784%
  • Speaking & faculty fees$9500%
  • Grants$9720%
  • Travel & lodging$27,8597%
  • Food & beverage$9,3342%
  • Education$21,5486%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$381,729 in reported general payments places this provider in the 95th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$184,537
Medicare patients
317
Services billed
1,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide43$1,963
Azelastine Hcl33$1,838
Fluticasone Propionate12$250

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →